41153-30-4 Usage
Description
BOC-L-4-Fluorophe, also known as Boc-Phe(4-F)-OH, is an amino acid building block derived from the L-phenylalanine amino acid. It is characterized by its white to light yellow crystal powder appearance and is a crucial component in the synthesis of peptides. The growing peptide drug market highlights the importance of fast and reliable peptide synthesis, making BOC-L-4-Fluorophe a valuable compound in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
BOC-L-4-Fluorophe is used as an amino acid building block for peptide synthesis. Its role in the development of peptide drugs is significant, as it contributes to the creation of various therapeutic agents with potential applications in treating a wide range of diseases and conditions.
Used in Peptide Drug Market:
BOC-L-4-Fluorophe is used as a key component in the synthesis of peptide drugs, which are increasingly becoming important in the pharmaceutical industry. BOC-L-4-Fluorophe's ability to facilitate fast and reliable peptide synthesis makes it a valuable asset in the development of new and innovative treatments for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 41153-30-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,1,5 and 3 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 41153-30:
(7*4)+(6*1)+(5*1)+(4*5)+(3*3)+(2*3)+(1*0)=74
74 % 10 = 4
So 41153-30-4 is a valid CAS Registry Number.
InChI:InChI=1/C14H18FNO4/c1-14(2,3)20-13(19)16-11(12(17)18)8-9-4-6-10(15)7-5-9/h4-7,11H,8H2,1-3H3,(H,16,19)(H,17,18)/t11-/m0/s1
41153-30-4Relevant articles and documents
Structure-Activity Relationships of cyclo(l -Tyrosyl- l -tyrosine) Derivatives Binding to Mycobacterium tuberculosis CYP121: Iodinated Analogues Promote Shift to High-Spin Adduct
Rajput, Sunnia,McLean, Kirsty J.,Poddar, Harshwardhan,Selvam, Irwin R.,Nagalingam, Gayathri,Triccas, James A.,Levy, Colin W.,Munro, Andrew W.,Hutton, Craig A.
supporting information, p. 9792 - 9805 (2019/11/13)
A series of analogues of cyclo(l-tyrosyl-l-tyrosine), the substrate of the Mycobacterium tuberculosis enzyme CYP121, have been synthesized and analyzed by UV-vis and electron paramagnetic resonance spectroscopy and by X-ray crystallography. The introduction of iodine substituents onto cyclo(l-tyrosyl-l-tyrosine) results in sub-μM binding affinity for the CYP121 enzyme and a complete shift to the high-spin state of the heme FeIII. The introduction of halogens that are able to interact with heme groups is thus a feasible approach to the development of next-generation, tight binding inhibitors of the CYP121 enzyme, in the search for novel antitubercular compounds.
NOVEL COMPOUNDS WITH DUAL ACTIVITY
-
Page/Page column 24; 25, (2017/04/01)
The invention generally relate to novel compounds and uses thereof in preventing antifouling by unicellular organisms and in attracting cells from multicellular organisms.
Antiretroviral hydrazine derivatives
-
, (2008/06/13)
The invention relates to compounds of formula STR1 and salts, pharmaceutical compositions, intermediates and processes of preparation thereof.
